CIK 0000943819 · Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980152841
- Phone
- 8587462400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-24 | Farrell Michael J. Chairman and CEO | Grant or award · ResMed Common Stock Options | +33,288 | $250.52 | $8.3M | 33,288 |
| 2025-11-24 | FARRELL PETER C Director | Grant or award · ResMed Common Stock Options | +1,331 | $250.52 | $333K | 1,331 |
| 2025-11-24 | Mowad-Nassar Nicole Director | Grant or award · ResMed Common Stock Options | +1,331 | $250.52 | $333K | 1,331 |
| 2025-11-20 | Leong Justin Chief Product Officer | Grant or award | +1,848 | 29,028 | ||
| 2025-11-20 | Hernandez John Director | Grant or award | +1,073 | 5,118 | ||
| 2025-11-20 | Mowad-Nassar Nicole Director | Grant or award | +536 | 777 | ||
| 2025-11-20 | Tan Desney Director | Grant or award | +1,073 | 6,002 | ||
| 2025-11-20 | Gill Harjit Director | Grant or award | +1,073 | 10,940 | ||
| 2025-11-20 | Drexler Karen Director | Grant or award | +1,073 | 10,602 | ||
| 2025-11-20 | Burt Carol Director | Grant or award | +1,073 | 2,156 | ||
| 2025-11-20 | TAYLOR RONALD R Director | Grant or award | +1,073 | 24,771 | ||
| 2025-11-20 | Sandercock Brett Chief Financial Officer | Grant or award | +2,710 | 88,495 | ||
| 2025-11-20 | Farrell Michael J. Chairman and CEO | Grant or award | +13,551 | 473,520 | ||
| 2025-11-20 | Farrell Michael J. Chairman and CEO | Shares withheld for taxes | −7,297 | 466,223 | ||
| 2025-11-20 | DelOrefice Christopher Director | Grant or award | +1,073 | 2,423 | ||
| 2025-11-20 | De Witte Jan Director | Grant or award | +1,073 | 6,316 | ||
| 2025-11-20 | FARRELL PETER C Director | Grant or award | +536 | 70,773 | ||
| 2025-11-14 | FARRELL PETER C Director | Option exercise | +11,442 | $101.64 | $1.2M | 77,552 |
| 2025-11-14 | FARRELL PETER C Director | Shares withheld for taxes | −7,314 | $244.46 | $1.8M | 70,238 |
| 2025-11-14 | FARRELL PETER C Director | Option exercise · ResMed Common Stock Options | −11,442 | 0 |
Page 4 of 18 · 355 trades